← All stories
Tech
Did AstraZeneca's (LSE:AZN) Lung Cancer Data Just Reset The Blue-Chip Mood Today?
Highlights AstraZeneca rose after disclosing results from late-stage lung cancer studies. The pharmaceutical group was cited among the supports for London's leading benchmark today. Oncology remains the largest contributor to the company's…
Covered by 1 outlet
All coverage · 1 article